We discuss the case of a young patient presenting with euglycemic DKA. Say what? How common is this entity and what is the impact of a new class of diabetic medication? We answer these important questions and much more on this episode.
You can get CME credit for this episode here! Click here for CME Account Creation Instructions
Ventilated ED patients may be at high risk for awareness with paralysis, thereby increasing the risk of long-term psychological sequelae. In this podcast, we...
This month Mike McCurdy rejoins the podcast to discuss the ATHOS-3 trial. Mike was one of the co-authors on this impressive publication and gives...
Our understanding and management of patients with COVID-19 infection continues to rapidly evolve, almost on a daily basis. In this podcast, we discuss current...